Impact of Immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors: A Randomized Controlled Phase II Trial
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• Patients with liver tumors planned for major hepatectomies (defined as resection of \>/= 3 liver segments)
• Age above 18 years
• ASA class I-III
Locations
Other Locations
India
Dr. Shraddha Patkar
RECRUITING
Mumbai
Contact Information
Primary
Dr. Shraddha Patkar, MD MCh
drshraddhapatkar@gmail.com
9820074818
Backup
Dr Mahesh Goel, MBBS, MD
drmaheshgoel@gmail.com
9820504492
Time Frame
Start Date: 2025-10-03
Estimated Completion Date: 2028-01-31
Participants
Target number of participants: 100
Treatments
Experimental: Intervention Arm
Immunomax® Powder- Participant in this group will receive Immunomac Powder 7 consecutive days preceding surgery in a dose of 6-9 scoops (120-180g per day), based on their bodyweight.
No_intervention: Standard Arm
Participant in this group will be advised to continue with their usual oral intake. Patients in this group assessed as having malnutrition will be provided with a standard nutritional supplement (Fortisip®, Nutricia) twice daily (providing 600 kcal energy, 24 g protein), in addition to their usual intake, for the period preceding and including 7 days prior to surgery
Related Therapeutic Areas
Sponsors
Leads: Tata Memorial Centre